Ropivacaine HCl monohydrate
CAS No. 132112-35-7
Ropivacaine HCl monohydrate ( Ropivacaine hydrochloride monohydrate | Ropivacaine HCl | LEA-103 HCl | LEA 103 )
产品货号. M19457 CAS No. 132112-35-7
盐酸罗哌卡因是一种麻醉剂,通过可逆地抑制钠离子流入来阻断神经纤维的脉冲传导。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 10MG | ¥313 | 有现货 |
|
| 25MG | ¥446 | 有现货 |
|
| 50MG | ¥625 | 有现货 |
|
| 100MG | ¥889 | 有现货 |
|
| 200MG | ¥1314 | 有现货 |
|
| 500MG | ¥2223 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
| 1 mL x 10 mM in DMSO | ¥174 | 有现货 |
|
生物学信息
-
产品名称Ropivacaine HCl monohydrate
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述盐酸罗哌卡因是一种麻醉剂,通过可逆地抑制钠离子流入来阻断神经纤维的脉冲传导。
-
产品描述Ropivacaine HCl is an anaesthetic agent and blocks impulse conduction in nerve fibres through inhibiting sodium ion influx reversibly.(In Vivo):Epidural administration of Ropivacaine hydrochloride monohydrate effectively blocks neuropathic pain (both mechanical allodynia and heat hyperalgesia) without induction of analgesic tolerance and significantly delays the development of neuropathic pain produced by peripheral nerve injury.Ropivacaine hydrochloride monohydrate inhibits pressure-induced increases in filtration coefficient (Kf) without affecting pulmonary artery pressure (Ppa), pulmonary capillary pressures (Ppc), and zonal characteristics (ZC).Ropivacaine hydrochloride monohydrate prevents pressure-induced lung edema and associated hyperpermeability as evidence by maintaining PaO2, lung wet-to-dry ratio and plasma volume in levels similar to sham rats.Ropivacaine hydrochloride monohydrate inhibits pressure-induced NO production as evidenced by decreased lung nitro-tyrosine content when compared to hypertensive lungs.
-
体外实验——
-
体内实验Epidural administration of Ropivacaine hydrochloride monohydrate effectively blocks neuropathic pain (both mechanical allodynia and heat hyperalgesia) without induction of analgesic tolerance and significantly delays the development of neuropathic pain produced by peripheral nerve injury.Ropivacaine hydrochloride monohydrate inhibits pressure-induced increases in filtration coefficient (Kf) without affecting pulmonary artery pressure (Ppa), pulmonary capillary pressures (Ppc), and zonal characteristics (ZC).Ropivacaine hydrochloride monohydrate prevents pressure-induced lung edema and associated hyperpermeability as evidence by maintaining PaO2, lung wet-to-dry ratio and plasma volume in levels similar to sham rats.Ropivacaine hydrochloride monohydrate inhibits pressure-induced NO production as evidenced by decreased lung nitro-tyrosine content when compared to hypertensive lungs. Animal Model:Adult Sprague-Dawley rats (300–400g)Dosage:1 μM Administration:Infusion (added to the perfusate reservoir) Result:Attenuated pressure-dependent increases in filtration coefficient (Kf).
-
同义词Ropivacaine hydrochloride monohydrate | Ropivacaine HCl | LEA-103 HCl | LEA 103
-
通路Others
-
靶点Other Targets
-
受体Others
-
研究领域Others
-
适应症Anaesthesia; Labour pain; Postoperative pain
化学信息
-
CAS Number132112-35-7
-
分子量328.88
-
分子式C17H29ClN2O2
-
纯度>98% (HPLC)
-
溶解度DMSO:62 mg/mL (199.44 mM);Ethanol:<1 mg/mL;Water:46 mg/mL (147.97 mM)
-
SMILESO.Cl.CCCN1CCCC[C@H]1C(=O)Nc1c(C)cccc1C
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Simpson D et al. Drugs 2005 65(18) 2675-2717.
产品手册
关联产品
-
1-Phenylpyrrole
1-Phenylpyrrole 是大鼠肝脏微粒体中 CYP450 依赖性单加氧酶活性的抑制剂。
-
TDO-IN-1
TDO-IN-1 是色氨酸 2,3-双加氧酶 (TDO) 的选择性抑制剂 (IC50=0.62 μM),具有口服活性,且对 TDO 的选择性高于吲哚胺-2,3-双加氧酶 (IDO, IC50 >100 μM)。TDO-IN-1 能够逆转肿瘤组织的局部免疫耐受来抑制体内肿瘤生长。
-
F1324
F1324 is a potent, high affinity peptidic inhibitor of B cell lymphoma 6 (BCL6) with an IC50 of 1 nM. F1324 exhibits binding t1/2 value of 441 s and has strong inhibition activity against BCL6 PPI.
021-51111890
购物车()
sales@molnova.cn

